Logo image of IDAI

T STAMP INC-CLASS A (IDAI) Stock Fundamental Analysis

NASDAQ:IDAI - Nasdaq - US8730485088 - Common Stock - Currency: USD

3.21  -0.19 (-5.59%)

Fundamental Rating

2

IDAI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. IDAI may be in some trouble as it scores bad on both profitability and health. IDAI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year IDAI has reported negative net income.
In the past year IDAI has reported a negative cash flow from operations.
In the past 5 years IDAI always reported negative net income.
In the past 5 years IDAI always reported negative operating cash flow.
IDAI Yearly Net Income VS EBIT VS OCF VS FCFIDAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -181.46%, IDAI is doing worse than 93.62% of the companies in the same industry.
With a Return On Equity value of -294.46%, IDAI is not doing good in the industry: 82.62% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -181.46%
ROE -294.46%
ROIC N/A
ROA(3y)-143.75%
ROA(5y)-151.58%
ROE(3y)-1082.04%
ROE(5y)-798.26%
ROIC(3y)N/A
ROIC(5y)N/A
IDAI Yearly ROA, ROE, ROICIDAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 1K -1K 2K -2K 3K

1.3 Margins

Looking at the Gross Margin, with a value of 64.85%, IDAI is in line with its industry, outperforming 45.04% of the companies in the same industry.
In the last couple of years the Gross Margin of IDAI has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for IDAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.67%
GM growth 5Y-0.44%
IDAI Yearly Profit, Operating, Gross MarginsIDAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

3

2. Health

2.1 Basic Checks

IDAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IDAI has more shares outstanding
Compared to 5 years ago, IDAI has more shares outstanding
IDAI has a worse debt/assets ratio than last year.
IDAI Yearly Shares OutstandingIDAI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
IDAI Yearly Total Debt VS Total AssetsIDAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

IDAI has an Altman-Z score of -15.16. This is a bad value and indicates that IDAI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of IDAI (-15.16) is worse than 90.78% of its industry peers.
IDAI has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of IDAI (0.25) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z -15.16
ROIC/WACCN/A
WACC10.89%
IDAI Yearly LT Debt VS Equity VS FCFIDAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 -5M

2.3 Liquidity

IDAI has a Current Ratio of 2.32. This indicates that IDAI is financially healthy and has no problem in meeting its short term obligations.
IDAI has a better Current ratio (2.32) than 68.09% of its industry peers.
IDAI has a Quick Ratio of 2.32. This indicates that IDAI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.32, IDAI is in the better half of the industry, outperforming 68.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 2.32
IDAI Yearly Current Assets VS Current LiabilitesIDAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.30% over the past year.
The Revenue for IDAI has decreased by -34.72% in the past year. This is quite bad
Measured over the past years, IDAI shows a small growth in Revenue. The Revenue has been growing by 7.88% on average per year.
EPS 1Y (TTM)38.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.18%
Revenue 1Y (TTM)-34.72%
Revenue growth 3Y-5.74%
Revenue growth 5Y7.88%
Sales Q2Q%-4.92%

3.2 Future

IDAI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.53% yearly.
IDAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 63.49% yearly.
EPS Next Y83.14%
EPS Next 2Y38.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year138.65%
Revenue Next 2Y63.49%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IDAI Yearly Revenue VS EstimatesIDAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 1M 2M 3M 4M 5M
IDAI Yearly EPS VS EstimatesIDAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -5 -10 -15 -20

1

4. Valuation

4.1 Price/Earnings Ratio

IDAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IDAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IDAI Price Earnings VS Forward Price EarningsIDAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IDAI Per share dataIDAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

A more expensive valuation may be justified as IDAI's earnings are expected to grow with 38.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.53%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IDAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

T STAMP INC-CLASS A

NASDAQ:IDAI (7/11/2025, 8:23:17 PM)

3.21

-0.19 (-5.59%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-13 2025-08-13
Inst Owners8.29%
Inst Owner Change0%
Ins Owners3.25%
Ins Owner Change0.45%
Market Cap7.96M
Analysts82.86
Price Target8.16 (154.21%)
Short Float %2.54%
Short Ratio1.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)82.09%
Min Revenue beat(2)-23.6%
Max Revenue beat(2)187.77%
Revenue beat(4)1
Avg Revenue beat(4)35.89%
Min Revenue beat(4)-23.6%
Max Revenue beat(4)187.77%
Revenue beat(8)3
Avg Revenue beat(8)35.8%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-28.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)60%
EPS NY rev (1m)0%
EPS NY rev (3m)48.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.61
P/FCF N/A
P/OCF N/A
P/B 1.95
P/tB 7.54
EV/EBITDA N/A
EPS(TTM)-8.59
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)-3.35
OCFYN/A
SpS1.23
BVpS1.65
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -181.46%
ROE -294.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.85%
FCFM N/A
ROA(3y)-143.75%
ROA(5y)-151.58%
ROE(3y)-1082.04%
ROE(5y)-798.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.67%
GM growth 5Y-0.44%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 121.1%
Cap/Sales 28.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.32
Quick Ratio 2.32
Altman-Z -15.16
F-Score3
WACC10.89%
ROIC/WACCN/A
Cap/Depr(3y)114.05%
Cap/Depr(5y)117.17%
Cap/Sales(3y)20.66%
Cap/Sales(5y)19.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.18%
EPS Next Y83.14%
EPS Next 2Y38.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.72%
Revenue growth 3Y-5.74%
Revenue growth 5Y7.88%
Sales Q2Q%-4.92%
Revenue Next Year138.65%
Revenue Next 2Y63.49%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.01%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-45.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.18%
OCF growth 3YN/A
OCF growth 5YN/A